Liver Safety of Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD): Interim Data from a European Union Post-Authorization Safety Study (EUPASS)

Category Primary study
JournalJournal of the American Society of Nephrology
Year 2023
This article has no abstract
Epistemonikos ID: 50b66895cce00b2b8a823794270830dc2ae0d0a3
First added on: Feb 16, 2025